Two new prostate cancer drugs could extend men's lives by two years by slowing its painful spread. Many men with prostate cancer fall into a sort of medical limbo after they have been treated for prostate cancer but before the disease has spread. International teams of physicians in two studies experimented with using a drug approved to treat later stage prostate cancer and another entirely new therapy to treat men in this in-between phase. Affecting more one in every nine men here, most forms of prostate cancer grow slowly, meaning they may not be detectable for many years. One of the primary markers of prostate cancer is high levels of prostate-specific antigen (PSA).

Source: The Star February 10, 2018 08:15 UTC